Impact of Hyperglycemia and Age on Outcomes in Patients With Acute Myeloid Leukemia
Susan Storey, PhD, RN, AOCNS®; and Diane Von Ah, PhD, RN, FAAN
ONF
10.1188/16.ONF.595-601
Description
Purpose/Objectives: To examine the prevalence and impact of hyperglycemia on health outcomes (number of neutropenic days, infection, and hospital length of stay) in patients hospitalized for acute myeloid leukemia (AML) receiving initial induction therapy.
Design: Retrospective, descriptive study.
Setting: A large urban hospital in Indianapolis, IN.
Sample: 103 patients with AML and a subset of 41 patients aged 65 years or older.